Lisata Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
21.50
|
|
Average Rating
|
4.50
|
|
# Strong Buys
|
1
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.90
|
-7.88
|
-6.98
|
-775.56%
|
|
2022-06-30
|
-1.45
|
-1.65
|
-0.20
|
-13.79%
|
|
2022-03-31
|
-1.45
|
-1.05
|
0.40
|
27.59%
|
|
2021-12-31
|
-2.17
|
-1.65
|
0.52
|
23.96%
|
|
2021-09-30
|
-2.25
|
-1.80
|
0.45
|
20.00%
|
|
2021-06-30
|
-2.17
|
-1.50
|
0.67
|
30.88%
|
|
2021-03-31
|
-1.27
|
-2.85
|
-1.58
|
-124.41%
|
|
2020-12-31
|
-3.80
|
-4.20
|
-0.40
|
-10.53%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-10.58
|
|
2021-12-31
|
-7.80
|
|
2020-12-31
|
-8.43
|
|
2019-12-31
|
-1.87
|
|
2018-12-31
|
-1.66
|
|
2017-12-31
|
-2.13
|
|
2016-12-31
|
-5.25
|
|
2015-12-31
|
-16.90
|
|
2014-12-31
|
-16.90
|
|
2013-12-31
|
-18.80
|
|
2012-12-31
|
-29.00
|
|
2011-12-31
|
-86.00
|
|
2009-12-31
|
-4528.08
|
|
2008-12-31
|
-2334.88
|
|
2007-12-31
|
-20860.03
|
|
2005-12-31
|
-12830.07
|
|
2003-12-31
|
-70463.79
|